The one-year Addiction Psychiatry Fellowship at Mayo Clinic's campus in Rochester, Minnesota, provides psychiatrists with advanced training in comprehensive addictions treatment, including screening, diagnosis, behavioral therapies, pharmacotherapies, systems management, treatment planning and consultation.
Specifically, the program enables fellows to:
- Master the pharmacology and neuropharmacology of all the major substances of dependence, including alcohol, amphetamines, stimulants, hallucinogens, opioids, benzodiazepines, sedative hypnotics and nicotine, and acquire knowledge of signs and symptoms of use and dependence, withdrawal and overdose, as well as brain systems that subserve addictive processes
- Understand and be able to recognize the social, psychological, medical and psychiatric problems that frequently occur with psychoactive substance use
- Gain knowledge in the epidemiology of, prevention of, and genetic and congenital aspects of substance use disorders
- Develop awareness of economic and cost-effectiveness issues in providing health care services to patients with substance use disorders
- Understand the theoretical underpinnings of the various psychotherapeutic modalities used in the treatment of psychoactive substance dependence
- Develop a new research project or join a project in progress, including the Mayo Clinic Samuel C. Johnson Genomics of Addiction Program studies
The Addiction Psychiatry Fellowship is accredited by the Accreditation Council for Graduate Medical Education.
Graduates are eligible to take the addiction psychiatry subspecialty certification exam offered by the American Board of Psychiatry and Neurology.